BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10498840)

  • 1. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC; Fan SH; Guerrini R; Caló G
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.
    Chiou LC
    J Biomed Sci; 2000; 7(3):232-40. PubMed ID: 10810242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T; Miyahara S; Takasaki M; Kannan H
    Brain Res; 2001 Jan; 890(1):147-53. PubMed ID: 11164777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray.
    Chiou LC; Liao YY; Guerrini R; Calo' G
    Eur J Pharmacol; 2005 May; 515(1-3):47-53. PubMed ID: 15896734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
    Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices.
    Liao YY; Teng SF; Lin LC; Kolczewski S; Prinssen EP; Lee LJ; Ho IK; Chiou LC
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):977-89. PubMed ID: 21029514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of an inwardly rectifying K+ conductance by orphanin-FQ/nociceptin in vasopressin-containing neurons.
    Slugg RM; Rønnekleiv OK; Grandy DK; Kelly MJ
    Neuroendocrinology; 1999 May; 69(5):385-96. PubMed ID: 10343180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ.
    Meis S; Pape HC
    J Neurosci; 1998 Oct; 18(20):8133-44. PubMed ID: 9763460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of the antagonistic effect of (-)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111) on nociceptin/orphanin FQ-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Jiang F; Chiou LC
    Eur J Pharmacol; 2011 Apr; 657(1-3):84-8. PubMed ID: 21300055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CompB (J-113397), selectively and competitively antagonizes nociceptin activation of inwardly rectifying K(+) channels in rat periaqueductal gray slices.
    Chiou LC; Fan SH
    Neuropharmacology; 2002 Jun; 42(7):987-92. PubMed ID: 12069909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
    Yakimova KS; Pierau FK
    Neurosci Lett; 1999 Oct; 274(2):87-90. PubMed ID: 10553944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro.
    Connor M; Vaughan CW; Chieng B; Christie MJ
    Br J Pharmacol; 1996 Dec; 119(8):1614-8. PubMed ID: 8982509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
    Xu IS; Wiesenfeld-Hallin Z; Xu XJ
    Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR; Chang JK; Kenigs VA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.